Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page
Webinars

Reducing Clinician and Patient Biases against Vaginal Insert Therapies




This is an internet-based activity that should take 1 hour to complete. To receive CME/CE, learners should: 1) take the pre-test, 2) listen to the webinar, and 3) take the post-test.

Learning Objectives

At the conclusion of this presentation, participants should be able to:

  • Explain the potential benefits, uses, indications, efficacy, and adverse effects of currently available vaginal insert therapies
  • Use evidence-based resources to effectively dispel patient fears and misconceptions about the vagina, female anatomy, and vaginal insert therapies from adolescence, menopause and beyond.
  • Apply appropriate patient-centered communication skills to conversations about vaginal bias

Accreditation Information

Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses: This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour. Credit can be applied toward the nursing continuing education requirements of most professional organizations and State Boards of Nursing.

Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through an educational grant from Teva Pharmaceuticals.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Target Audience

This activity is designed for physicians, nurse midwives, nurse practitioners, physician assistants, students, educators, and researchers who focus on reproductive health care, family practice or internal medicine.

Disclosures

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

  • Sheryl A. Kingsberg, PhD (Planner) - Dr. Kingsberg receives consulting fees from Pfizer, Shionogi, Trimel, Sprout, BioSante, NovoNordisk, and Palatin. Dr. Kingsberg has ownership interest and receives consulting fees from Viveve.
  • Suzan Goodman, MD, MPH (Planner), Beth Kruse, MS, CNM, ARNP (Planner), Mary King, PhD (Medical Writer), Beth Jordan Mynett, MD (ARHP Medical Director), Amy Swann, MA, CAE (Vice President), Lanita L. Williams, MPH (ARHP Program Manager), have nothing to disclose.

Back